Home
About Us
Hycells Profile
Corporate Culture
Contact Us
Sample Service
Immune Cells
Hepatocytes
Stem Cells
Featured Products
Cultivation Products
Testing Products
Other Products And Instruments
Technical Service Platform
Specialized Sample Services
Conventional Drug Efficacy Evaluation
Granulocyte Function Experiment
Whole Blood/Serum Test
Drug Immunogenicity Testing
Drug Blood Toxicity Testing
Technology Center
Frequently Asked Questions
Operational Skills
Training Salon
Blog
Company News
Industry Trends
Laws Regulations
Language
中文版
English
All Categories >
02
2023-03
Rising to the Challenge in 2023: Full-Throttle Momentum | Hycells’s 2023 Spring Festival Gala Was a Resounding Success!
With the arrival of spring, all things come back to life. On February 24, despite their busy schedules, all colleagues at Hycells headed to an Anji resort to kick off the company’s three-day, two-night Spring Annual Gathering for 2023.
2023-03-02
15
2023-02
Hycells Birthday Celebration | Wishing you a wonderful holiday and joyful moments together!
On this auspicious occasion, may all be well and in harmony with the times. With each passing year, we share in the joy together. Growth arrives unexpectedly, yet birthdays come as scheduled. Behind every beautiful moment lies relentless effort and dedication. Each birthday is worthy of our heartfelt anticipation and celebration.
2023-02-15
06
2023-01
Holiday Notice for the Spring Festival at Hycells Biotechnology!
2023-01-06
21
2022-12
Ding! Please sign for your Christmas Eve gift!
With the adjustment of epidemic prevention and control measures, Shanghai has entered a new phase in its fight against the virus. On this invisible battlefield, each of us—striving to live well and working diligently—is a warrior. We are deeply grateful to every colleague who remains steadfast at their post or stays home, tirelessly battling the virus while continuing to do their job. You are all truly outstanding.
2022-12-21
Hycells Bio | Dedicated to Research on Cell and Animal Models for Drug Development
Shanghai Hycells Biotechnology Co., Ltd. has long been deeply engaged in the cell and gene therapy segment of large-molecule drug development. Since its inception, the company has leveraged a solid customer base and years of accumulated R&D service expertise to establish robust technological barriers, delivering highly satisfactory services that have earned a strong reputation among new-drug R&D enterprises. As a result, it has forged long-term, stable partnerships with numerous leading CROs, cell therapy companies, and gene therapy firms. Moving forward, we will continue to optimize our clinical, technical, and business management systems as well as our service processes, thereby providing collaborative partners in the biopharmaceutical sector with services that meet even higher standards.
19
To Our Original Aspiration, Embarking on a New Journey | Hycells Biological Relocates to New Headquarters
2022 was an extraordinary year for everyone. Although the pandemic restricted our movements, it only intensified our collective commitment to safeguarding human life and health. In November 2022, Hycells Biotechnology turned a new, milestone chapter in its history by relocating to a brand-new facility—marking a significant leap forward in the company’s manufacturing and R&D capabilities and providing a powerful boost to its sustained growth. Thanks to the concerted efforts of colleagues across all departments, we officially moved into our new premises on November 21, 2022.
2022-12-19